| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |